Millennium Sustainable Ventures Corp.

OTC: MILC · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ New York City, NY · New YorkCIK 0001358656Reports USD

#1071 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ 12GM —SS 48

v0.1 · 25/100 weight · pillars only

↑ listing tenure, return on assets · ↓ disclosure history, operating margin

Methodology →

Revenue TTM

$456.4k

Rev growth YoY (TTM)

+584982.1%

Net income (FY)

-$7.2M

Employees

Market cap

$2.2k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$41.8k$41.8k2021

Net income-$7.2M-$7.2M2021

Operating income-$7.4M-$7.4M2021

Total assets$44.6M$44.6M2021

Liabilities$42.7M$42.7M2021

Equity$1.9M$1.9M2021

Revenue by segment

Filed disclosures · FY2021

By product

Cannabis100%

By geography

Not disclosed.

The read

Millennium Sustainable Ventures Corp. booked $41.8k in FY2021 revenue — among the slowest-growing Healthcare companies we track, at a -17269.5% net margin.

Peers · Healthcare

Cotinga Pharmaceuticals Inc.——Urologix, Inc.——ForU Holdings, Inc.——Viveve Medical, Inc.——

Neighbors

New York →

JPMorgan Chase & Co.$182.4B72B Morgan Stanley$34.3B60C The Goldman Sachs Group, Inc.——Philip Morris International Inc.$40.6B86A American Express Company$41.3B78B+Citigroup Inc.$85.2B56C

Key facts

CEODavid H. Lesser

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersNew York City, NY

ExchangeOTC: MILC

Employees96

IPO date2006-09-21

Latest filings

8-K2023-09-11 8-K2023-03-31 8-K2023-03-01 10-Q2022-11-14 8-K2022-09-15 10-Q2022-08-15 DEF 14A2022-08-08 8-K2022-07-28

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.